FDA Approves Expanded Indication for Telix’s Illuccix to Include Patient Selection for PSMA-Directed Radioligand Therapy Read more
Ipsen receives new FDA PDUFA date for investigational palovarotene for the treatment of people with FOP Read more
Evotec announces progress in strategic protein degradation partnership with Bristol Myers Squibb Read more
Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer Read more
Prelude Therapeutics Announces Clinical Trial Collaboration with BeiGene to Evaluate PRT2527 in Combination with Zanubrutinib in Hematologic Cancers Read more
ImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio Read more
Exclusive Attendee List Released For the Inaugural mRNA Process Development & Manufacturing Summit Europe Read more
China National Medical Products Administration accepts regulatory submission for Nucala (mepolizumab) in severe eosinophilic asthma Read more